Stroke Trial, Recruiting NCT07113041 Sponsor: Kessler Foundation Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07113041
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People who were diagnosed with a stroke (affecting the main part of the brain) at least 6 months before the screening, confirmed by a neurological examination or MRI scan
  • People who have balance and postural control problems, as measured by a specific balance assessment tool (called the Berg Balance Scale), with a score of 50 or below
  • People who are able to stand upright, with or without support, for at least 20 seconds
  • People who are able to walk at least 10 metres, with or without a walking aid
  • People who are not planning to change their medications over the next four months
  • People who have enough cognitive ability to understand spoken instructions and follow study procedures, as assessed using a specific consent capacity tool (confirm with trial site)

Who may not be able to join:

  • People who are currently taking part in regular physiotherapy or another research study focused on balance
  • People who have had a brainstem stroke (a stroke affecting the lower part of the brain)
  • People who cannot have an MRI scan — for example, due to metal implants in the body or severe fear of enclosed spaces (claustrophobia)
  • People who had nerve, muscle, or bone/joint problems in their legs before their stroke, or who experience ongoing pain or difficulty maintaining blood pressure when standing
  • People who have a scalp or skin condition (such as psoriasis or eczema) near the area where stimulation would be applied
  • People with severe vision problems (such as spatial neglect) or significant hearing difficulties that could affect their ability to take part in the study
  • People with any other neurological condition or psychiatric diagnosis, such as severe anxiety or schizophrenia
  • People who are pregnant or planning to become pregnant
  • People who have been diagnosed with alcohol or substance misuse within the last 3 years
  • People with reasons they cannot safely receive a specific type of brain stimulation used in the study (called TMS) — for example, metal implants in the head, a history of seizures or epilepsy that has not responded to treatment, or current use of medications that affect seizure thresholds (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vikram Shenoy Handiru,, PhD, Kessler Foundation

Phone: 9733243578

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kessler Foundation
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Berg Balance Scale (BBS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov